EvoLution of Neoadjuvant TreatMent in 'Triple-negative' or 'HER-2-positive' Breast Cancer Diagnosed in the EaRly Phase

NCT06894173 · clinicaltrials.gov ↗
RECRUITING
Status
1000
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS